Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NSE/DCAL stock hub

NSE/DCAL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/DCALis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

29.4B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/DCAL

In the news

Latest news · NSE/DCAL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E24.7

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC3

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/DCAL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

168

Groups with data

Currency

INR

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,106
Employees Change	-26%
Employees Change Percent	-2.3
Enterprise value	INR 48.6B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Biotechnology
Isin	INE385W01011
Last refreshed	2026-05-10
Market cap	INR 29.4B
Price	INR 187
Price currency	INR
Rev Per Employee	25,287,884.27x
Sector	Healthcare
Sic	2833
Symbol	nse/DCAL
Website	https://imdcal.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.05%
EV Earnings	40.94x
EV/EBIT	19.87x
EV/EBITDA	9.08x
EV/Sales	1.74x
P/B ratio	0.46x
P/E ratio	24.69x
P/S ratio	1.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.75%
EBITDA Margin	17.3%
Gross margin	80.15%
Gross Profit	INR 22.4B
Gross Profit Growth	15.26%
Gross Profit Growth Q	-0.8%
Gross Profit Growth3 Y	8.46%
Gross Profit Growth5 Y	10.01%
Net Income	INR 1.2B
Net Income Growth Years	1%
Net Income Growth5 Y	23.18%
Pretax Margin	3.09%
Profit Margin	4.25%
Profit Per Employee	INR 1.1M
Profitable Years	1
Roa5y	0.79
Roe5y	-1.15
ROIC	2.95
Roic5y	1.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.02%
Cagr3y	14.61%
Cagr5y	0.28%
EPS Growth Years	1
EPS Growth5 Y	23.3
Revenue Growth	5.55x
Revenue Growth Q	5.49x
Revenue Growth Quarters	1x
Revenue Growth Years	4x
Revenue Growth3 Y	5.77x
Revenue Growth5 Y	8.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 6.3B
Debt	INR 25.6B
Debt EBITDA	INR 4.78
Debt Equity	INR 0.4
Equity	INR 63.6B
Interest Coverage	1.48
Net Cash	INR -19.3B
Net Cash By Market Cap	INR -65.65
Net Debt EBITDA	INR 3.98
Net Debt Equity	INR 0.3
Tangible Book Value	INR 14.9B
Tangible Book Value Per Share	INR 95.2
WACC	6.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.16%
Dividend per share	INR 0
Last Dividend	INR 0.2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.02%
200-day SMA	232
3Y total return	50.57%
50-day SMA	166.9
50-day SMA vs 200-day SMA	50under200
5Y total return	1.39%
All Time High	396.4
All Time High Change	-52.9%
All Time High Date	2018-01-23
All Time Low	46.05
All Time Low Change	305.43%
All Time Low Date	2020-03-30
ATR	8.87
Beta	0.64
Beta1y	0.84
Beta2y	0.45
Ch YTD	-24.59
High	193.5
High52	322
High52 Date	2025-09-23
High52ch	-42.01%
Low	186.7
Low52	128.5
Low52 Date	2026-03-30
Low52ch	45.29%
Ma50ch	11.83%
Price vs 200-day SMA	-19.52%
RSI	61.19
RSI Monthly	46.88
RSI Weekly	44.99
Sharpe ratio	0.13x
Sortino ratio	0.31
Total Return	0.16%
Tr YTD	-24.59
Tr1m	23.87%
Tr1w	0.18%
Tr3m	-7.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2.4B
Operating Income Growth	72.8
Operating Income Growth Q	-57.91
Operating Income Growth3 Y	31.08
Operating Income Growth5 Y	15.38
Operating margin	8.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,131,867%
Shares Insiders	5.5%
Shares Institutions	6.76%
Shares Out	156,783,095
Shares Qo Q	-0.4%
Shares Yo Y	-0.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	373,331.15x
Bv Per Share	405.7
Ch1m	23.87
Ch1w	0.18
Ch1y	0.02
Ch3m	-7.06
Ch3y	50.57
Ch5y	1.39
Ch6m	-24.97
Change	-2.88%
Change From Open	-2.48
Close	192.2
Days Gap	-0.41
Depreciation Amortization	2,391,650,000
Dollar Volume	36,155,015.1
Earnings Date	2026-05-22
EBIT	INR 2.4B
EBITDA	INR 4.8B
EPS	INR 7.58
F Score	2
Fiscal Year End	March
Founded	1,983
Graham Number	263.07924
Graham Upside	40.91
Income Tax	INR -323.3M
Is Primary Listing	1
Last Earnings Date	2026-02-03
Last Report Date	2025-12-31
Lynch Fair Value	INR 176
Lynch Upside	-5.87
Ma150	220.7
Ma150ch	-15.41%
Ma20	174.9
Ma20ch	6.72%
Next Earnings Date	2026-05-22
Open	191.5
Position In Range	0
Price Date	2026-05-08
Price EBITDA	INR 6.07
Ptbv Ratio	1.97
Relative Volume	0.49x
Revenue	27,968,400,000x
Tax By Revenue	-1.16x
Tr6m	-24.97%
Volume	193,653

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/DCAL pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/DCAL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/DCAL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.8%

Share of float held by funds and institutions

Insider ownership

+5.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

NSE/DCAL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.2

Neutral momentum band

Price vs 200-day MA

-19.5%

50/200-day relationship not available

Beta (5Y)

0.64

Less volatile than the market

Sharpe ratio

0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/DCAL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/DCAL stock rating?

nse/DCAL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/DCAL analysis?

The full report lives at /stocks/nse/DCAL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/DCAL?

The latest report frames nse/DCAL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/DCAL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.